Risk Factors for Multidrug-resistant Pseudomonas aeruginosa Among Hospitalized Patients at a Malaysian Hospital

被引:0
作者
Nasir, M. D. Mohd [1 ]
Nurnajwa, M. H. [2 ]
Lay, J. [2 ]
Teoh, J. C. [2 ]
Syafinaz, A. N. [2 ]
Niazlin, M. T. [2 ]
机构
[1] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Biomed Sci, Serdang 43400, Selangor De, Malaysia
[2] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Med Microbiol & Parasitol, Serdang 43400, Selangor De, Malaysia
来源
SAINS MALAYSIANA | 2015年 / 44卷 / 02期
关键词
Antibiotic exposure; hospital stay; multidrug resistant Pseudomonas aeruginosa; risk factor;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A case-control study was conducted based on medical cases of 100 hospitalized patients with Pseudomonas aeruginosa-isolation at a Malaysian hospital. Cases with 50 multidrug-resistant P. aeruginosa MDRPA and 50 non-multidrug-resistant P. aeruginosa (NMDRPA) were randomly included and compared with socio-demographic and clinical data of the patients, using Chi- square and Fisher's exact tests as the statistical tool. Analysis found no significant association between MDRPA with ages, gender and ethnicity of patients (p>0.050). Other risk factors being investigated were invasive procedure, immunosuppression, bedridden and clinical diagnosis such as central nervous- and respiratory-system disorder, as well as antibiotic exposure during hospitalization and duration of hospital stay with only the last two were found to have significant association (p=0.035 and 0.019, respectively). Some other studies also reported a similar association indicating that the two factors could serve as an important predictive tool for isolation of MDRPA. More studies involving a larger sampling size are warranted to establish the association.
引用
收藏
页码:257 / 260
页数:4
相关论文
共 9 条
[1]   Multidrug-resistant Pseudomonas aeruginosa: Risk factors and clinical impact [J].
Aloush, V ;
Navon-Venezia, S ;
Seigman-Igra, Y ;
Cabili, S ;
Carmeli, Y .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (01) :43-48
[2]  
Amutha R., 2009, INDIAN J SCI TECHNOL, V11, P11
[3]   Detection of SHV type extended-spectrum B-lactamase and risk factors in pseudomonas aeruginosa clinical isolates [J].
Bahmani, Nasrin ;
Ramazanzadeh, Rashid .
PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2013, 29 (03) :788-792
[4]  
Ghibu Laura, 2010, Rev Med Chir Soc Med Nat Iasi, V114, P1012
[5]   Fluoroquinolone-resistant Pseudomonas aeruginosa:: risk factors for acquisition and impact on outcomes [J].
Hsu, DI ;
Okamoto, MP ;
Murthy, R ;
Wong-Beringer, A .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (04) :535-541
[6]  
Idris SNA, 2012, SE ASIAN J TROP MED, V43, P116
[7]   Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance [J].
Lodise, Thomas P. ;
Miller, Christopher D. ;
Graves, Jeffrey ;
Furuno, Jon P. ;
McGregor, Jessina C. ;
Lomaestro, Ben ;
Graffunder, Eileen ;
McNutt, Louise-Anne .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (02) :417-422
[8]   A New Strategy for Healthcare-Associated Pneumonia: A 2-Year Prospective Multicenter Cohort Study Using Risk Factors for Multidrug-Resistant Pathogens to Select Initial Empiric Therapy [J].
Maruyama, Takaya ;
Fujisawa, Takao ;
Okuno, Masataka ;
Toyoshima, Hirokazu ;
Tsutsui, Kiyoyuki ;
Maeda, Hikaru ;
Yuda, Hisamichi ;
Yoshida, Masamichi ;
Kobayashi, Hiroyasu ;
Taguchi, Osamu ;
Gabazza, Esteban C. ;
Takei, Yoshiyuki ;
Miyashita, Naoyuki ;
Ihara, Toshiaki ;
Brito, Veronica ;
Niederman, Michael S. .
CLINICAL INFECTIOUS DISEASES, 2013, 57 (10) :1373-1383
[9]  
Shanthi M., 2009, J Assoc Physicians India, V57, P638